These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2533553)

  • 1. Glycosaminoglycans in urine, articular and periarticular tissues in streptozotocin diabetes in rats.
    Mavrikakis ME; Kontoyannis D; Karli J; Kittas C; Giagiakou E; Moulopoulou A; Koutras DA
    Endocrinol Exp; 1989 Dec; 23(4):295-304. PubMed ID: 2533553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
    Adewole SO; Ojewole JA
    Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relations between doses of streptozotocin and pathosis in induced diabetes mellitus].
    Nishigaki A; Noma H; Kakizawa T
    Shikwa Gakuho; 1989 Mar; 89(3):639-62. PubMed ID: 2533996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass.
    Takada J; Machado MA; Peres SB; Brito LC; Borges-Silva CN; Costa CE; Fonseca-Alaniz MH; Andreotti S; Lima FB
    Metabolism; 2007 Jul; 56(7):977-84. PubMed ID: 17570261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lipoic acid treatment worsens energy imbalances in streptozotocin-induced diabetic rats.
    Luz J; Zemdegs JC; Amaral LS
    Diabetes Metab; 2009 Apr; 35(2):137-42. PubMed ID: 19101190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
    Kumar GS; Shetty AK; Salimath PV
    J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of anthocyanin dye from grapes on experimental diabetes].
    Jankowski A; Jankowska B; Niedworok J
    Folia Med Cracov; 2000; 41(3-4):5-15. PubMed ID: 11339016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of streptozotocin administration upon the serotonin content of the pancreas and small intestine of the rat.
    Richter G; Ballmann M; Conlon JM
    Horm Metab Res; 1986 Oct; 18(10):663-5. PubMed ID: 2946636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of short-term diabetes on osteocytic lacunae of alveolar bone. A histomorphometric study.
    Villarino ME; Sánchez LM; Bozal CB; Ubios AM
    Acta Odontol Latinoam; 2006; 19(1):23-8. PubMed ID: 17121195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
    Suryanarayana P; Saraswat M; Petrash JM; Reddy GB
    Mol Vis; 2007 Jul; 13():1291-7. PubMed ID: 17679931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in expression of adrenomedullin in the myocardium of streptozotocin-induced diabetic rats.
    He RX; Gu CL; Shen F; Zhang XM
    Chin Med J (Engl); 2007 Feb; 120(3):187-91. PubMed ID: 17355819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
    Bae SK; Yang SH; Lee SJ; Kwon JW; Kim WB; Lee DC; Lee MG
    Eur J Pharm Sci; 2005 Jun; 25(2-3):337-45. PubMed ID: 15911231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P; Kaviarasan K; Pugalendi KV
    Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts].
    Song XD; Chen CZ; Dong B; Shi YY; Zhang W; Yan LS; Luo GA
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):605-9. PubMed ID: 14766075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.